Why Is National Vision (EYE) Down 10.1% Since Last Earnings Report?

National Vision reported Q2 2026 adjusted EPS of $0.25, up 38.9% year over year and 47.1% above consensus, while revenue rose 2.5% to $498.8 million and beat estimates by 1.4%. The company raised the low end of adjusted EPS guidance to $0.94 from $0.85, but narrowed comparable-sales growth guidance to 3%-5% from 3%-6%; gross margin declined 58 bps to 58.2%. Shares have fallen 10.1% since the report, while consensus estimates have declined 40%, reflecting investor concern over slowing traffic, mixed brand-level sales, and downward earnings revisions despite the quarterly beat.

Analysis

EYE’s post-print weakness is rational if the market is discounting the quality rather than the magnitude of the earnings beat. The earnings outperformance appears disproportionately dependent on overhead leverage and timing, while the underlying self-pay traffic signal is negative and gross-margin pressure persists. That combination limits the probability that a modestly higher EPS floor translates into a sustained valuation rerating over the next 1-3 months.

Managed-care mix is a near-term stabilizer but can be structurally dilutive to unit economics if reimbursement growth trails labor, lab, and lens costs. America’s Best remains the relevant earnings engine; weak performance in smaller banners is less material today but raises execution risk around the store-growth algorithm. A price-sensitive consumer also increases competitive substitution risk versus Walmart optical, Costco, and Warby Parker (WRBY), particularly if EYE responds to traffic softness through promotions.

Cash conversion deserves more scrutiny than the balance-sheet headline: operating cash flow is declining while capital intensity is rising, and repurchases reduce flexibility if comps weaken. The reported 40% consensus-estimate decline is inconsistent with the guidance change and should be reconciled for fiscal-year mapping, one-time items, or analyst coverage changes before treating it as a clean negative signal. If it is genuine, EYE may face another de-rating despite apparently inexpensive headline valuation.

Contrarian upside requires proof that traffic has bottomed without incremental discounting. A sequential improvement in self-pay transactions, stable gross margin, and America’s Best comps above the upper end of guidance would create a credible 6-12 month margin-recovery narrative; absent that evidence, this is a watchlist turnaround rather than a high-conviction long.

Key Decisions for Investors

• Maintain no directional core position ahead of the next earnings release; the current evidence does not separate a temporary traffic issue from a deteriorating value-consumer demand backdrop.
• Set an alert to initiate a small long EYE only if the next update shows positive self-pay traffic and gross-margin stabilization sequentially; target a 15-20% rerating over 6-12 months, with thesis invalidated by comparable-sales guidance below 3% or further gross-margin erosion.
• For relative-value exposure, monitor a long EYE / short WRBY pair only after estimate-revision data are validated. The trade works if EYE’s managed-care scale and cost actions restore earnings conversion while WRBY’s premium discretionary demand weakens; exit if EYE’s America’s Best traffic remains negative for two consecutive quarters.
• Do not underwrite additional buybacks as a catalyst until free-cash-flow conversion improves after store investment. A rising revolver draw, lower operating cash flow, or accelerated promotional activity would be a signal to avoid the equity rather than add on weakness.